do glp 1 slow metabolism GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Paige S Lynch, NP +

Improper reconstitution Shaking the vial, using non-sterile technique, or reconstituting with the wrong type or volume of water are errors that compromise the entire vial

Seiwerth S, Milavic M, Vukojevic J, Gojkovic S, Krezic I, Vuletic LB, et al

Glucagon-like peptide-1 (GLP-1) receptor agonists are medications licensed in the UK for managing type 2 diabetes and, in some cases, obesity

Supplementary Information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material

Note that there are drugs in development as sub-cutaneous (SC) administration (like current Ozempic, Wegovy, Zepbound, Mounjaro), whilst we wont need to wait to long for the oral versions of these drugs to come out (next 6-12 months)

Simonson, Darleen A